Search research articles
Contact Us
Filters
Showing results (241-250 of 316) with videos related to
Page
of 32
Sort By:
Neuro-Oncology
|
January 31, 2026
Distinct tumor immune microenvironmental (TIME) landscapes drive divergent immunotherapy responses in glioblastoma
Linqian Weng, Krish Skandha Gopalan, Mélanie Guyot, et al.
Cancer Immunology Research
|
November 7, 2023
A Metabolic Gene Survey Pinpoints Fucosylation as a Key Pathway Underlying the Suppressive Function of Regulatory T Cells in Cancer
Sotiria Pinioti, Himal Sharma, Nina C Flerin, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 6, 2026
Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis
Aaron Caeyman, Giulia Mammone, Lisa Kinget, et al.
Scientific Reports
|
April 29, 2017
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
Matthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, et al.
Cell Death & Disease
|
December 20, 2022
DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis
Maria Vedunova, Victoria Turubanova, Olga Vershinina, et al.
Frontiers in Immunology
|
July 29, 2020
Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology
Els Wauters, Karin Thevissen, Carine Wouters, et al.
The EMBO Journal
|
January 19, 2012
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Abhishek D Garg, Dmitri V Krysko, Tom Verfaillie, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 12, 2024
Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab
Yana Beulque, Lisa Kinget, Eduard Roussel, et al.
Nature Medicine
|
May 7, 2021
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
Ayse Bassez, Hanne Vos, Laurien Van Dyck, et al.
Oncoimmunology
|
October 14, 2024
Trial watch: anticancer vaccination with dendritic cells
Francisca Borges, Raquel S Laureano, Isaure Vanmeerbeek, et al.
Page
of 32
Search research articles
Search
Showing results (241-250 of 316) with videos related to
Sort By:
Page
of 32
Neuro-Oncology
|
January 31, 2026
Distinct tumor immune microenvironmental (TIME) landscapes drive divergent immunotherapy responses in glioblastoma
Linqian Weng, Krish Skandha Gopalan, Mélanie Guyot, et al.
Cancer Immunology Research
|
November 7, 2023
A Metabolic Gene Survey Pinpoints Fucosylation as a Key Pathway Underlying the Suppressive Function of Regulatory T Cells in Cancer
Sotiria Pinioti, Himal Sharma, Nina C Flerin, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 6, 2026
Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis
Aaron Caeyman, Giulia Mammone, Lisa Kinget, et al.
Scientific Reports
|
April 29, 2017
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
Matthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, et al.
Cell Death & Disease
|
December 20, 2022
DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis
Maria Vedunova, Victoria Turubanova, Olga Vershinina, et al.
Frontiers in Immunology
|
July 29, 2020
Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology
Els Wauters, Karin Thevissen, Carine Wouters, et al.
The EMBO Journal
|
January 19, 2012
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Abhishek D Garg, Dmitri V Krysko, Tom Verfaillie, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 12, 2024
Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab
Yana Beulque, Lisa Kinget, Eduard Roussel, et al.
Nature Medicine
|
May 7, 2021
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
Ayse Bassez, Hanne Vos, Laurien Van Dyck, et al.
Oncoimmunology
|
October 14, 2024
Trial watch: anticancer vaccination with dendritic cells
Francisca Borges, Raquel S Laureano, Isaure Vanmeerbeek, et al.
Page
of 32